Back to search results

CAR-T in Relapsed/Refractory Multiple Myeloma

Abroad (travel likely)RecruitingPHASE2

Conditions

Multiple Myeloma Refractory · Multiple Myeloma in Relapse

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • National University of Medical Sciences, Clinical Trial Unit, Rawalpindi, Punjab Province, Pakistan

  • National University of Medical Sciences, Clinical Trial Unit, Rawalpindi, Punjab Province, Pakistan

    Contact: Study coordinator (Nadia Sial, PhD) · nadiaharif@gmail.com · +923315582265
    Contact: Study coordinator (Tariq Ghafoor, MBBS,FCPS,FRCP(Ire),FRCP(Glas) · drtariqghafoor@gmail.com · +923008519006
    Contact: Principal Investigator (Tariq Ghafoor, MBBS,FCPS,FRCP(Ire),FRCP(Glas)
    Raheel Iftikhar, MBBS,FCPS(Med),FCPS(Cl Haem (Sub-investigator)
    Hammad Javed, MBBS,FCPS(Med), FCPS(Cl Haem (Sub-investigator)
    Memoona Khan, MBBS, FCPS (Haem (Sub-investigator)
    Aamir Aslam Awan, MBBS,FCPS(Paeds (Sub-investigator)
    Nadia Sial, PhD (Sub-investigator)
    Arif Sadiq, MBBS,FCPS(Haem),FCPS(CL Haem (Sub-investigator)
    Saleem Ahmed Khan, MBBS,FCPS (Sub-investigator)
    Babar Saeed Khan, MBBS (Sub-investigator)
Study leads

  • Maryam Khan, MBBS, MRCP (UK), FCPS(Cl Haem)

    Study Chair

    National University of Medical Sciences

  • Tariq Ghafoor

    Principal Investigator

    National University of Medical Sciences

View source on ClinicalTrials.gov(opens in a new tab)